Search

everythinglearnresearchcommunity

for

Search:↓

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Nanotechnology improves Clomiphene citrate's effectiveness and reduces side effects for treating ovulatory disorders.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

Norgalanthamine from Crinum asiaticum may help hair grow.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

Phyto-vesicles of β-sitosterol may effectively treat hair loss.

LH and hCG reduce certain protein levels in women's skin.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Cyproterone acetate is an effective treatment for women with acne, hair loss, and excessive hair growth.

Basonuclin helps keratinocytes multiply and prevents them from fully maturing.

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

A new method accurately measures long-term hormone levels in hair.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Mice hair follicles take in the amino acid cystine.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Using certain plant growth regulators together improves the cloning of the medicinal plant Eclipta alba.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

These new skin treatments are safer and more effective with minimal side effects.

CS12192 effectively treats alopecia areata with better safety than current options.